News

First targeted treatment to boost survival for esophageal cancer

Patients with a specific type of esophageal cancer survived longer when they were given the latest lung cancer drug, according to trial results.

Fecal testing shows effectiveness for screening of familial colorectal cancer

Fecal immunochemical tests may be as effective as colonoscopies when it comes to detecting colorectal cancer among first-degree relatives of patients with colorectal cancer.

Exercise therapy benefits breast cancer survivors

Exercise offers several benefits for breast cancer survivors, including reduced symptoms of lymphedema, according to a new study.

CT lung screening appears cost-effective

A new statistical analysis of results from the National Lung Screening Trial concludes that performing low-dose computerized tomography (CT) screening can be cost-effective.

Collaboration yields new methods to treat tumors with antennas

Two engineering researchers have challenged a commonly held idea about tumor ablation.

Classifying gene mutations in neuroblastoma may point to improved treatments

Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which patients are more likely to respond to the drugs that target these mutations.

Diagnostic grading system developed for cancer-related weight loss

Diagnostic grading system developed for cancer-related weight loss

New grading system for cancer-linked weight loss includes independent prognostic significance of BMI and percent weight loss.

BRCA-related tumors respond to olaparib

Olaparib, an experimental oral cancer drug, has shown an overall tumor response rate of 26% in advanced cancers associated with BRCA1 and BRCA2 mutations, according to recent research.

Biopsies overused in diagnosing lung cancer, according to Medicare cost analysis

Biopsies are the most costly tool associated with lung cancer diagnosis, according to research.

Risk stratification model aids lung cancer staging and treatment decisions

A risk stratification model, based on lymph node characteristics, can confirm a negative classification of lung cancer with a high level of confidence.

Conference Coverage

Biopsies overused in diagnosing lung cancer, according to Medicare cost analysis

Biopsies are the most costly tool associated with lung cancer diagnosis, according to research.

Early palliative care can cut hospital readmissions for cancer patients

A new, collaborative model in cancer care aims to reduce the rates at which patients go to intensive care or are readmitted to the hospital after discharge.

3-D printed facial prosthesis offers new hope for eye cancer patients after surgery

By utilizing both facial scanning software and 3-D printing, researchers have developed an inexpensive way to make facial prostheses for patients with eye cancer.

Subsidies help breast cancer patients adhere to hormone therapy

A federal prescription-subsidy program for low-income Medicare recipients has increased adherence to hormone therapy to prevent breast cancer recurrence after surgery, according to recent data.

New test helps in choosing best treatment for ovarian cancer

Researchers have devised a new test to help doctors diagnose ovarian tumors and choose the most appropriate treatment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs